JOINT DISLOCATION REDUCTION

This adverse event was reported 56 times

These drugs are most commonly taken by patients reporting JOINT DISLOCATION REDUCTION:

# Drug Count
0 ALENDRONATE SODIUM 26
1 ETANERCEPT 13
2 RISEDRONATE SODIUM 12
3 ACETAMINOPHEN 11
4 AZATHIOPRINE 11
5 ACETAMINOPHEN 500MG 10
6 ACETAMINOPHEN TABLET EXTENDED RELEASE 10
7 PAIN RELIEVER 10
8 CALCIUM 9
9 ERGOCALCIFEROL 9
See all common drugs associated with JOINT DISLOCATION REDUCTION

JOINT DISLOCATION REDUCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
1 Aluminum Complex [EPC] 9 0.0004
2 Calcitonin [EPC] 1 0.0003
3 Provitamin D2 Compound [EPC] 9 0.0003
4 Influenza A M2 Protein Inhibitor [EPC] 2 0.0001
5 Non-Standardized Plant Allergenic Extract [EPC] 2 0.0001
6 Purine Antimetabolite [EPC] 11 0.0001
7 Antirheumatic Agent [EPC] 9 0.0001
8 Nonergot Dopamine Agonist [EPC] 1 0.0001
9 Calcium [EPC] 9 0.0001
See all drug classes enriched for association with JOINT DISLOCATION REDUCTION